SCHEMBL30537992

SCHEMBL30537992

O=c1[nH]c2cc(Cl)ccc2s1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CMA1 P23946 1/20 1.00
KDM4E B2RXH2 3/20 0.61
ALDH1A1 P00352 3/20 0.61
GAA P10253 2/20 0.61
CYP1A2 P05177 2/20 0.61
CYP2C9 P11712 1/20 0.61
HPGD P15428 1/20 0.61
PSMB8 P28062 1/20 0.61
CYP2C19 P33261 1/20 0.61
PGR P06401 1/20 0.56
PDE3B Q13370 3/20 0.53
PDE3A Q14432 3/20 0.53
GRIN2D O15399 1/20 0.48
GRIN3B O60391 1/20 0.48
GRIN1 Q05586 1/20 0.48
GRIN2A Q12879 1/20 0.48
GRIN2B Q13224 1/20 0.48
GRIN2C Q14957 1/20 0.48
GRIN3A Q8TCU5 1/20 0.48
NPSR1 Q6W5P4 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL507970 1.00 CMA1 (1.00) CMA1KDM4EALDH1A1GAACYP1A2
SCHEMBL6190902 0.86 CMA1 (0.75) CMA1KDM4EALDH1A1GAACYP1A2
SCHEMBL3859325 0.77 CMA1 (0.59) CMA1KDM4EALDH1A1GAACYP1A2
SCHEMBL30534236 0.76 CMA1 (0.61) CMA1KDM4EALDH1A1GAAPGR
SCHEMBL9497675 0.76 PSMB8 (1.00) CMA1KDM4EALDH1A1GAACYP1A2
SCHEMBL8286761 0.76 CMA1 (0.61) CMA1ALDH1A1PGRPDE3BPDE3A
SCHEMBL289800 0.76 CMA1 (0.61) CMA1KDM4EALDH1A1GAACYP1A2
SCHEMBL29477415 0.76 CMA1 (0.61) CMA1KDM4EALDH1A1GAACYP1A2
SCHEMBL30613119 0.76 CMA1 (0.61) CMA1KDM4EALDH1A1GAAHPGD
SCHEMBL3224706 0.76 CMA1 (0.61) CMA1KDM4EALDH1A1GAAPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240294482-A1 METHOD FOR CATALYTICALLY ACTIVATING CARBON DIOXIDE AS CARBONYLATION REAGENT WITH INORGANIC SULFUR INNER MONGOLIA UNIVERSITY OF TECHNOLOGY (CN) 2024-09-05 US disclosed
CN-110483492-B Dipeptidyl peptidase I inhibitors 阿斯利康(瑞典)有限公司 2023-07-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294482-A1 METHOD FOR CATALYTICALLY ACTIVATING CARBON DIOXIDE AS CARBONYLATION REAGENT WITH INORGANIC SULFUR TST, CBR3, SMOX CMA1 810/4885KDM4E 1906/4885ALDH1A1 639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.